Industrial chemical found in Cubicin

Apr 10, 2008

The U.S. Food and Drug Administration said Cubist Pharmaceuticals is warning that an industrial chemical has been found in the antibiotic Cubicin.

Cubist, a Massachusetts-based drug maker, said the chemical 2-mercaptobenzothiazole (MBT) has been found in reconstituted Cubicin stored in ReadyMED pumps, which are made by Cardinal Health. "At this time, Cubist recommends against using ReadyMED elastomeric infusion pumps with Cubicin," Cubist said in a letter to medical professionals last week.

Cubist spokeswoman Eileen McIntyre told The Wall Street Journal the company thinks the contamination came from the drug pumps. Cardinal Health said it is investigating the issue.

Cubist said MBT, which is used in the manufacturing of rubber, was not detected in samples from Eclipse pumps or control samples. The chemical has been associated with an increased risk of tumors in laboratory rats, Cubist said.

Copyright 2008 by United Press International

Explore further: Study examines FDA influence on design of pivotal drug studies

add to favorites email to friend print save as pdf

Related Stories

Knightscope K5 on security patrol roams campus

38 minutes ago

A Mountain View, California-based company called Knightscope designs and builds 5-feet, 300-pound security guards called K5, but anyone scanning last week's headlines has already heard about them, with the ...

US northeast braces for flooding after record snow

20 hours ago

Weather forecasters and emergency officials warned Sunday that melting snow would lead to heavy flooding in parts of the US northeast, with hundreds of thousands of people told to brace for fast-rising waters.

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

6 hours ago

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

Health care M&A leads global deal surge

Nov 23, 2014

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.